Moraima Lagos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Moraima Lagos has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Gustavo Vilchez
Department of Obstetrics and Gynecology, University of Missouri-Kansas City School of Medicine, 2310 Holmes St. STE 713, Kansas City, MO, 64108, USA.
5 shared publications Jing Dai
Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan, USA
3 shared publicationsRobert J. Sokol
Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan, USA
3 shared publications- David Félix Lazón Mansilla
Universidad Nacional Federico Villareal
2 shared publications - Komal Kumar
University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, USA
2 shared publications - Bérkely Smith Mayhua Gutiérrez
Universidad Nacional Federico Villareal
1 shared publication
Latest Publications
- Open Access
- 22 January 2024
- Published by Professionals On Line SAC in World Health Journal
- Vol. 5 (1) , 07-15
Plomo en sangre y su relación con hemoglobina y hematocrito en niños expuestos a la contaminación minera, Apurímac 2023
Exposure to heavy metals causes a high level of lead in the blood, which causes various problems in various organs, including a deficit in the production of hemoglobin, which causes anemia. This circumstance was the impetus to carry out this research study. The objective of the research was to determine the relationship between blood lead levels and hemoglobin and hematocrit levels in children aged 0 to 11 years exposed to mining pollution in the community of the district and province of Andahuaylas in the department of Apurímac. . A non-experimental quantitative and descriptive design was used. 98 minors from 0 to 11 years of age, registered in the district and province of Andahuaylas in the department of Apurímac, participated in the "lead in blood and its relationship with hemoglobin and hematocrit" campaign from April to May 2023. The study on anemia found that fifty percent (50%) of the subjects did not have anemia. The percentages of mild (6 subjects), moderate (33 subjects), and severe (9 subjects) anemia were 6.1% to 33.7% and 9.2%, respectively. Regarding lead poisoning, 64 (65.3%) of the subjects did not show significant levels, while 34 (34.7%) of the subjects showed toxic levels. The relationship of lead levels with hemoglobin was not significantly influenced by age group, sex or area of residence. Hemoglobin decreases by 0.755 for every one unit increase in blood lead level, with a p-value <0.001 and a 95% confidence interval of -0.839 - 0.671. This study demonstrates a significant correlation between blood lead levels and low hemoglobin levels (corrected for height), underscoring the importance of interventions focused on prevention and health promotion in at-risk populations.
- 22 January 2024
- Published by Professionals On Line SAC in World Health Journal
- Vol. 5 (1) , 07-15
Open AccessPlomo en sangre y su relación con hemoglobina y hematocrito en niños expuestos a la contaminación minera, Apurímac 2023
Exposure to heavy metals causes a high level of lead in the blood, which causes various problems in various organs, including a deficit in the production of hemoglobin, which causes anemia. This circumstance was the impetus to carry out this research study. The objective of the research was to determine the relationship between blood lead levels and hemoglobin and hematocrit levels in children aged 0 to 11 years exposed to mining pollution in the community of the district and province of Andahuaylas in the department of Apurímac. . A non-experimental quantitative and descriptive design was used. 98 minors from 0 to 11 years of age, registered in the district and province of Andahuaylas in the department of Apurímac, participated in the "lead in blood and its relationship with hemoglobin and hematocrit" campaign from April to May 2023. The study on anemia found that fifty percent (50%) of the subjects did not have anemia. The percentages of mild (6 subjects), moderate (33 subjects), and severe (9 subjects) anemia were 6.1% to 33.7% and 9.2%, respectively. Regarding lead poisoning, 64 (65.3%) of the subjects did not show significant levels, while 34 (34.7%) of the subjects showed toxic levels. The relationship of lead levels with hemoglobin was not significantly influenced by age group, sex or area of residence. Hemoglobin decreases by 0.755 for every one unit increase in blood lead level, with a p-value <0.001 and a 95% confidence interval of -0.839 - 0.671. This study demonstrates a significant correlation between blood lead levels and low hemoglobin levels (corrected for height), underscoring the importance of interventions focused on prevention and health promotion in at-risk populations.
- Open Access
- 1 February 2023
- Published by Fundacion Koinonia in CIENCIAMATRIA
- Vol. 9 (1) , 303-317
Anemia, parasitosis intestinal y rendimiento escolar
El objetivo general de la investigación consistió en determinar la relación entre anemia y parasitosis intestinal con el rendimiento académico en escolares del distrito de San Juan de Lurigancho 2022. La investigación fue de diseño no experimental y nivel correlacional; realizó en el ámbito geográfico que comprende el distrito de San Juan de Lurigancho, en niños de 3 a 5 años de centros educativos de inicial, Los resultados reflejaron que la parasitosis intestinal, se encontró una prevalencia de 16.9% con el examen directo de heces. La baja frecuencia de parasitosis hallada en esta investigación, indican una predisposición a las enteroparasitosis, probablemente debido a una adecuada higiene ambiental y condiciones socioeconómicas. Como conclusión se obtuvo que no hay correlación entre anemia, parasitosis y rendimiento académico. Según la prueba chi cuadrado indica que no hay relación entre anemia y rendimiento ni como factor asociado al rendimiento académico (OR= 0.731, no significativo).
- 1 February 2023
- Published by Fundacion Koinonia in CIENCIAMATRIA
- Vol. 9 (1) , 303-317
Open AccessAnemia, parasitosis intestinal y rendimiento escolar
El objetivo general de la investigación consistió en determinar la relación entre anemia y parasitosis intestinal con el rendimiento académico en escolares del distrito de San Juan de Lurigancho 2022. La investigación fue de diseño no experimental y nivel correlacional; realizó en el ámbito geográfico que comprende el distrito de San Juan de Lurigancho, en niños de 3 a 5 años de centros educativos de inicial, Los resultados reflejaron que la parasitosis intestinal, se encontró una prevalencia de 16.9% con el examen directo de heces. La baja frecuencia de parasitosis hallada en esta investigación, indican una predisposición a las enteroparasitosis, probablemente debido a una adecuada higiene ambiental y condiciones socioeconómicas. Como conclusión se obtuvo que no hay correlación entre anemia, parasitosis y rendimiento académico. Según la prueba chi cuadrado indica que no hay relación entre anemia y rendimiento ni como factor asociado al rendimiento académico (OR= 0.731, no significativo).
- Open Access
- 27 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27364
The Effectiveness of Pap and Visual Inspection With Acetic Acid (VIAA) Tests in Cervical Dysplasia Screenings During the COVID-19 Pandemic
This study was aimed at analyzing the validity and reliability of the Papanicolaou (Pap) test and visual inspection with acetic acid (VIAA) tests for cervical dysplasia screenings during the COVID-19 pandemic. This was a retrospective study of patients 21 years or older seen at the Luis Negreiros Primary Care Center in Lima, Peru between 2020 and 2021, who underwent cervical dysplasia screening (Pap or VIAA). Relevant information regarding patient age, date of service, and Pap and VIAA results were collected. Parallel form reliability was analyzed with chi-square tests, and phi, contingency and Cramer's V coefficients. The validity of these tests was analyzed through the calculation of the sensitivity, specificity, and positive and negative predictive values with confidence intervals. A p-value less than 0.05 indicated statistical significance. From 4,503 records, the sensitivity, specificity, and positive and negative predictive values for Pap were 0.87 (0.81-0.92), 1.0 (1.0-1.0), 1.0 (1.0-1.0) and 0.99 (0.98-0.99), respectively, and those for VIAA were 0.22 (0.14-0.31), 0.10 (0.10-0.10), 0.53 (0.38-0.69) and 0.10 (0.10-0.10), respectively. Test validity varied slightly according to patient age and the year of testing. The correlation, although significant, was inverse; chi-square = 39.18, p <0.001, phi = -0.60, contingency = 0.51 and Cramer’s V = -0.59. The validity and reliability of Pap testing and VIAA for cervical dysplasia screening significantly decreased during the COVID-19 pandemic. The correlation between these tests, although significant, was inverse. More larger-scale studies are needed to confirm these findings and understand the reasons underlying the decreased effectiveness of these tests.
- 27 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27364
Open AccessThe Effectiveness of Pap and Visual Inspection With Acetic Acid (VIAA) Tests in Cervical Dysplasia Screenings During the COVID-19 Pandemic
This study was aimed at analyzing the validity and reliability of the Papanicolaou (Pap) test and visual inspection with acetic acid (VIAA) tests for cervical dysplasia screenings during the COVID-19 pandemic. This was a retrospective study of patients 21 years or older seen at the Luis Negreiros Primary Care Center in Lima, Peru between 2020 and 2021, who underwent cervical dysplasia screening (Pap or VIAA). Relevant information regarding patient age, date of service, and Pap and VIAA results were collected. Parallel form reliability was analyzed with chi-square tests, and phi, contingency and Cramer's V coefficients. The validity of these tests was analyzed through the calculation of the sensitivity, specificity, and positive and negative predictive values with confidence intervals. A p-value less than 0.05 indicated statistical significance. From 4,503 records, the sensitivity, specificity, and positive and negative predictive values for Pap were 0.87 (0.81-0.92), 1.0 (1.0-1.0), 1.0 (1.0-1.0) and 0.99 (0.98-0.99), respectively, and those for VIAA were 0.22 (0.14-0.31), 0.10 (0.10-0.10), 0.53 (0.38-0.69) and 0.10 (0.10-0.10), respectively. Test validity varied slightly according to patient age and the year of testing. The correlation, although significant, was inverse; chi-square = 39.18, p <0.001, phi = -0.60, contingency = 0.51 and Cramer’s V = -0.59. The validity and reliability of Pap testing and VIAA for cervical dysplasia screening significantly decreased during the COVID-19 pandemic. The correlation between these tests, although significant, was inverse. More larger-scale studies are needed to confirm these findings and understand the reasons underlying the decreased effectiveness of these tests.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 982-990
Is mean platelet volume a better biomarker in pre‐eclampsia?
Aim: Platelet activation and destruction is a well recognized feature of pre‐eclampsia, but the current literature is contradictory regarding the role of mean platelet volume (MPV) in the diagnosis of this condition. We investigated whether MPV, compared with other routine laboratory markers such as platelet count, is a more significant biomarker of pre‐eclampsia, giving special attention to the intrapartum period.Methods: Biochemical and hematological markers along pregnancy including MPV were compared retrospectively between pre‐eclampsia and matched controls. Laboratory marker data were compared using independent t‐test. A logistic regression model was used to compare the strength of the associations of MPV and other routine markers such as platelet count with pre‐eclampsia. Receiver operating characteristic curves were plotted.Results: There were a total of 150 cases of pre‐eclampsia and 297 controls. In the pre‐eclampsia group, there were 60 cases of mild pre‐eclampsia (40.0%); 84, severe (56.0%); and six of eclampsia (4.0%). MPV was significantly higher in the pre‐eclampsia than in the control group (11.3 ± 1.0 vs 10.1 ± 0.8 fL, P = 0.002). On multivariate analysis, MPV was the only statistically significant biomarker of pre‐eclampsia (OR, 4.5; 95%CI: 1.5–13.7), and severe pre‐eclampsia (OR, 6.2; 95%CI: 1.6–24.6); performing superiorly to platelet count.Conclusions: Mean platelet volume is a more significant biomarker of pre‐eclampsia. It is more significantly associated with this condition than other routinely measured laboratory markers such as platelet count. MPV is routinely obtained on complete blood cell count and its utilization in the assessment of pre‐eclampsia in a clinical setting should continue to be evaluated.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 982-990
Is mean platelet volume a better biomarker in pre‐eclampsia?
Aim: Platelet activation and destruction is a well recognized feature of pre‐eclampsia, but the current literature is contradictory regarding the role of mean platelet volume (MPV) in the diagnosis of this condition. We investigated whether MPV, compared with other routine laboratory markers such as platelet count, is a more significant biomarker of pre‐eclampsia, giving special attention to the intrapartum period.Methods: Biochemical and hematological markers along pregnancy including MPV were compared retrospectively between pre‐eclampsia and matched controls. Laboratory marker data were compared using independent t‐test. A logistic regression model was used to compare the strength of the associations of MPV and other routine markers such as platelet count with pre‐eclampsia. Receiver operating characteristic curves were plotted.Results: There were a total of 150 cases of pre‐eclampsia and 297 controls. In the pre‐eclampsia group, there were 60 cases of mild pre‐eclampsia (40.0%); 84, severe (56.0%); and six of eclampsia (4.0%). MPV was significantly higher in the pre‐eclampsia than in the control group (11.3 ± 1.0 vs 10.1 ± 0.8 fL, P = 0.002). On multivariate analysis, MPV was the only statistically significant biomarker of pre‐eclampsia (OR, 4.5; 95%CI: 1.5–13.7), and severe pre‐eclampsia (OR, 6.2; 95%CI: 1.6–24.6); performing superiorly to platelet count.Conclusions: Mean platelet volume is a more significant biomarker of pre‐eclampsia. It is more significantly associated with this condition than other routinely measured laboratory markers such as platelet count. MPV is routinely obtained on complete blood cell count and its utilization in the assessment of pre‐eclampsia in a clinical setting should continue to be evaluated.
- 11 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 834-838
Contemporary analysis of maternal and neonatal morbidity after uterine rupture: A nationwide population‐based study
Aim: Uterine rupture is a rare but feared perinatal event. Despite abundant research and changes to guidelines implemented to reduce this complication, evaluation of whether uterine rupture still engenders significant maternal/neonatal morbidity has not been conducted. We analyzed recent cases of maternal/neonatal morbidity after uterine rupture.Methods: Deliveries complicated by uterine rupture from 2011 to 2012 in the United States were selected. Comparison cases without uterine rupture were used as controls. Measures of maternal/neonatal complications were compared with χ2 test, and relative risks were calculated. Logistic regression was used to identify the most significant complications. P < 0.05 indicated statistical significance.Results: From 7 922 016 births, 1925 cases of uterine rupture and 3765 controls were identified. Regression models retained four maternal outcomes; blood transfusion was the most common (~15%) and unplanned hysterectomy had the highest odds (~97‐fold). For newborns, the model retained three measures of morbidity; neonatal intensive care unit admission was the most common (~35%) and seizures had the highest odds (~20‐fold).Conclusions: Despite efforts to reduce complications, mothers remain at significant risk of unplanned hysterectomy and intensive care unit admission. Neonates are at sizeable risk for neonatal intensive care unit admission and seizures, recognized markers of long‐term neurobehavioral abnormality. Uterine rupture remains a major risk for mothers and babies.
- 11 February 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (5) , 834-838
Contemporary analysis of maternal and neonatal morbidity after uterine rupture: A nationwide population‐based study
Aim: Uterine rupture is a rare but feared perinatal event. Despite abundant research and changes to guidelines implemented to reduce this complication, evaluation of whether uterine rupture still engenders significant maternal/neonatal morbidity has not been conducted. We analyzed recent cases of maternal/neonatal morbidity after uterine rupture.Methods: Deliveries complicated by uterine rupture from 2011 to 2012 in the United States were selected. Comparison cases without uterine rupture were used as controls. Measures of maternal/neonatal complications were compared with χ2 test, and relative risks were calculated. Logistic regression was used to identify the most significant complications. P < 0.05 indicated statistical significance.Results: From 7 922 016 births, 1925 cases of uterine rupture and 3765 controls were identified. Regression models retained four maternal outcomes; blood transfusion was the most common (~15%) and unplanned hysterectomy had the highest odds (~97‐fold). For newborns, the model retained three measures of morbidity; neonatal intensive care unit admission was the most common (~35%) and seizures had the highest odds (~20‐fold).Conclusions: Despite efforts to reduce complications, mothers remain at significant risk of unplanned hysterectomy and intensive care unit admission. Neonates are at sizeable risk for neonatal intensive care unit admission and seizures, recognized markers of long‐term neurobehavioral abnormality. Uterine rupture remains a major risk for mothers and babies.
- 17 January 2017
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 31 (2) , 178-183
Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial
Objective: Evidence supports the need of dose-adjustment of several drugs according to body mass index (BMI) to prevent toxicity in the underweight, and ensure efficacy in obese women. However, for MgSO4 neuroprotection, the effect of BMI on maternal toxicity and fetal neuroprotection is understudied. We analyze the effect of BMI on maternal/infant outcomes after MgSO4. Methods: Secondary analysis of a clinical trial that studied MgSO4 neuroprotection. Maternal side effects, magnesium cord levels, and offspring cerebral palsy/death were analyzed along BMI strata using ANOVA and chi-square test. Logistic regression was used to calculate adjusted odds ratios according to the treatment and BMI, using nonobese that received placebo as reference. Interaction analyses were performed to validate differential efficacy of BMI. Results: From 2241 women, more side effects and higher magnesium cord levels were seen in underweight women (p = 0.05). MgSO4 neuroprotection was effective in the non-obese (p = 0.02), but not in obese women (p = 1.00). In multivariate analyses, MgSO4 significantly reduced cerebral palsy only in nonobese women. Interaction analyses showed the moderator effect of BMI (p = 0.169). Increasing MgSO4 dose in obese mothers may ensure neuroprotective efficacy without representing increased maternal risks. Considering costs of studying this association, current analysis may form the basis for reasonable practice.
- 17 January 2017
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 31 (2) , 178-183
Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial
Objective: Evidence supports the need of dose-adjustment of several drugs according to body mass index (BMI) to prevent toxicity in the underweight, and ensure efficacy in obese women. However, for MgSO4 neuroprotection, the effect of BMI on maternal toxicity and fetal neuroprotection is understudied. We analyze the effect of BMI on maternal/infant outcomes after MgSO4. Methods: Secondary analysis of a clinical trial that studied MgSO4 neuroprotection. Maternal side effects, magnesium cord levels, and offspring cerebral palsy/death were analyzed along BMI strata using ANOVA and chi-square test. Logistic regression was used to calculate adjusted odds ratios according to the treatment and BMI, using nonobese that received placebo as reference. Interaction analyses were performed to validate differential efficacy of BMI. Results: From 2241 women, more side effects and higher magnesium cord levels were seen in underweight women (p = 0.05). MgSO4 neuroprotection was effective in the non-obese (p = 0.02), but not in obese women (p = 1.00). In multivariate analyses, MgSO4 significantly reduced cerebral palsy only in nonobese women. Interaction analyses showed the moderator effect of BMI (p = 0.169). Increasing MgSO4 dose in obese mothers may ensure neuroprotective efficacy without representing increased maternal risks. Considering costs of studying this association, current analysis may form the basis for reasonable practice.
- 21 November 2015
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 294 (1) , 77-81
Risk of neonatal mortality according to gestational age after elective repeat cesarean delivery
Despite the well-known neonatal morbidity risks after elective cesarean deliveries performed before 39 weeks, there are scarce data regarding mortality risks. The objective of this study was to calculate the risk of neonatal mortality after elective repeat cesarean delivery (ERCD) by gestational age. The Linked Birth–Infant Death Data Files from the Vital Statistics Data of the Center for Disease Control and Prevention of the U.S. from 2004 to 2008 were analyzed. Only ERCD cases were included. Early death (<7 days), neonatal death (<28 days), and infant death (<1 year) were evaluated. A logistic regression model was used to calculate odds ratios. Cases delivered at 37–41 weeks were studied with 40 weeks as reference. A total of 483,052 cases were included for analysis. The distribution of rates and odds ratios for infant, neonatal and early death was U-shaped with the nadir at 39 weeks. There was a statistically significant increase in early death at 37 compared to 40 weeks’ gestation [OR (95 %) CI = 1.929(1.172–3.176)]. No statistical increase was found in any of the other mortality risks. There is an increased risk in early death with ERCD performed at 37 weeks. Our study provides evidence of neonatal harm beyond the reported morbidity risks.
- 21 November 2015
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 294 (1) , 77-81
Risk of neonatal mortality according to gestational age after elective repeat cesarean delivery
Despite the well-known neonatal morbidity risks after elective cesarean deliveries performed before 39 weeks, there are scarce data regarding mortality risks. The objective of this study was to calculate the risk of neonatal mortality after elective repeat cesarean delivery (ERCD) by gestational age. The Linked Birth–Infant Death Data Files from the Vital Statistics Data of the Center for Disease Control and Prevention of the U.S. from 2004 to 2008 were analyzed. Only ERCD cases were included. Early death (<7 days), neonatal death (<28 days), and infant death (<1 year) were evaluated. A logistic regression model was used to calculate odds ratios. Cases delivered at 37–41 weeks were studied with 40 weeks as reference. A total of 483,052 cases were included for analysis. The distribution of rates and odds ratios for infant, neonatal and early death was U-shaped with the nadir at 39 weeks. There was a statistically significant increase in early death at 37 compared to 40 weeks’ gestation [OR (95 %) CI = 1.929(1.172–3.176)]. No statistical increase was found in any of the other mortality risks. There is an increased risk in early death with ERCD performed at 37 weeks. Our study provides evidence of neonatal harm beyond the reported morbidity risks.
- 25 May 2015
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (8) , 1279-1282
Racial disparities in the optimal for induction of labor in low-risk term pregnancies: a national population-based study
The recommendation for elective induction of labor (IOL) is to await ≥ 39 weeks. Studies show earlier maturity of Blacks compared to Whites. The objective was to examine the effect of the Black race on the risk of intrapartum and neonatal complications after IOL. Black women with non-indicated IOL at 37-42 weeks were selected from the CDC-Birth Cohorts 2007-2010. Congenital anomalies, hypertension/diabetes, low-birth weight, breech presentation, previous cesarean and premature rupture of membranes were excluded. Intrapartum/neonatal complications were analyzed. Logistic regression was used to calculate adjusted odds ratios, using 39 weeks as reference. 311,264 black were compared with 2,451,774 deliveries of other races. For Blacks, the risks of cesarean delivery and intrapartum complications were lower at 38 weeks. Chance of vaginal delivery was greater at 38 weeks. Risks of neonatal complications was not increased at 38 compared to 39 weeks. Intrapartum complications were lower at 38 than at 39 weeks in Blacks with no increased risk of neonatal complications. Meconium staining and fetal distress were higher as early as at 40 weeks, perhaps due to accelerated maturation. While a 39-week goal is simple and benefits many patients, a more "personalized medicine" approach may benefit even more mothers and babies.
- 25 May 2015
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (8) , 1279-1282
Racial disparities in the optimal for induction of labor in low-risk term pregnancies: a national population-based study
The recommendation for elective induction of labor (IOL) is to await ≥ 39 weeks. Studies show earlier maturity of Blacks compared to Whites. The objective was to examine the effect of the Black race on the risk of intrapartum and neonatal complications after IOL. Black women with non-indicated IOL at 37-42 weeks were selected from the CDC-Birth Cohorts 2007-2010. Congenital anomalies, hypertension/diabetes, low-birth weight, breech presentation, previous cesarean and premature rupture of membranes were excluded. Intrapartum/neonatal complications were analyzed. Logistic regression was used to calculate adjusted odds ratios, using 39 weeks as reference. 311,264 black were compared with 2,451,774 deliveries of other races. For Blacks, the risks of cesarean delivery and intrapartum complications were lower at 38 weeks. Chance of vaginal delivery was greater at 38 weeks. Risks of neonatal complications was not increased at 38 compared to 39 weeks. Intrapartum complications were lower at 38 than at 39 weeks in Blacks with no increased risk of neonatal complications. Meconium staining and fetal distress were higher as early as at 40 weeks, perhaps due to accelerated maturation. While a 39-week goal is simple and benefits many patients, a more "personalized medicine" approach may benefit even more mothers and babies.